BioTech Stock Review EVRX Now Offering
Continuing Education Courses in Mold Remediation and Testing FARMINGDALE, N.Y.--(BUSINESS
WIRE)--Jan. 21, 2005--EnvironmentalRx (EVRX.PK) is pleased to announce EVRX will
now be offering continuing education in mold remediation and testing. This
course will be for professionals dealing with indoor air quality as well as
attorneys, architects and other corporate individuals in various industries.
Training will be located in Conroe, Texas at a selected educational facility. Environmenetal RX’s Iso-barrier was designed to control
infection by combating bacteria. It is ideal for use by hospitals to totally
decontaminate hospital beds between patients. Today's patients are given
antibiotics as part of a standard discharge. This is a result of the extremely high
incidence of infections resulting from contamination by other patients. The Iso-barrier will eliminate this need.
By using the Iso-barrier between patients, the hospital can completely
eliminate the risk of contaminating the next patient. This is consistent with EVRX's goal to step down medication
for all patients. EVRX's trained personnel can completely decontaminate a
hospital room in 30 minutes!
Please be advised that nothing within this email shall constitute a
solicitation or an invitation to get position in or sell any security mentioned
herein. This newsletter is neither a registered investment advisor nor
affiliated with any broker or dealer. This newsletter was paid 200,000 shares
from third party to send this report. All statements made are our express
opinion only and should be treated as such. We may own, take position and sell
any securities mentioned at any time. This report includes forward-looking
statements within the meaning of The Private Securities Litigation Reform Act
of 1995. These statements may include terms as "expect","
believe", "may", "will", "move","
undervalued" and "intend" or similar terms.
Attn: Subscribers, Analysts Stockbrokers
Environmental RX CORPORATION- (OTC: EVRX)
Symbol EVRX
Est Shares Outstanding 25,000,000
Recent Price $0.40
Accumulation Levels to $2.00
Exit Level $3.50
EVRX up 120% Since 01/03
STRONG BUY OPPORTUNITY
Bio Tech companies will be worth watching in 2005!!!
Patent Office Approves the Patent for
Environmental Iso-barrier Portable Decontamination Unit
Available for Use in Hospitals Immediately”
ABOUT THE COMPANY
Environmental Rx (OTC:EVRX)
is a multi faceted company that encompasses health related services, indoor air
quality, mold testing and remediation, products and information technology. The
company is organized around indoor air quality, pollutant pathways and the
methodology to overcome allergic, pathogenic and carcinogenic disease related
to microorganisms. Each division is serviced at the EVRX clinics springing up
nationwide. EVRX currently operates in Conroe, Texas and Long Island, NY.
We are giving EVRX our Highest Rating of STRONG-BUY.
“Environmental and bio-remediation is a rapidly growing $59
billion domestic industry, driven by increased federal, state, and local
litigation and legislation, and an increased awareness of environmental health
risks!”
THE TECHNOLOGY
Environmental RX’s “patented”-barrier product is designed for infection control and
combating bacteria. The Iso-barrier is a portable
unit that will encompass a hospital bed and decontaminate the entire bed. The Iso-barrier
is ideal for instruments and personal effects including an entire room for decontamination. The unit is based on 254
Nanometer short wave treatment and can be transported from room to room.
Mold remediation has been undertaken for a number of
years, increased litigation and legislation over the past several years has
sparked an explosion in public awareness and demand for effective assurance of
mold removal.The impact on the insurance industry alone has been
tremendous, with an estimated $3.0 billion spent in 2002 to settle mold
contamination claims. It is widely acknowledged that the eventual costs
of basic mold remediation will easily exceed the $20+ billion spent on asbestos
abatement over the last decade!
BREAKING NEWS HIGHLIGHTS
Increasing awareness
of the concerns which indoor air pollutants and contaminants pose to
individuals is also likely to stimulate even more impressive growth in the
niche markets where EVRX operates; “This concern is validated by the EPA’s
declarations that “indoor air pollution is America’s number
one environmental health concern” and that it is responsible for approximately
50% of all illnesses!”
REASONS TO OWN
THIS STOCK
1. Strong management and corporate vision
2. Patented product “Iso-barrier” has licensing
approval in Texas and is pending in several other states
3. No dominant player(s) in dynamic environmental remediation industry
4. Preparing audited financials; company is nearly “debt-free”
5. Company preparing filings and audits to become fully reporting to apply
for listing on the OTCBB
6. Tight float of 5mm low entry price!
7. Patented Iso-barrier product decontaminates a hospital room in 30 mins…saving time and money!
Safe Harbor Act Disclaimer: This press release contains
forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of>
1934, as amended (the "Exchange Act"), and as such, may involve risks
and uncertainties. Forward-looking
statements, which are based on certain assumptions and describe future plans,
strategies, and expectations,>
are generally identifiable by the use of words such as "believe,"
expect," "intend" "anticipate," estimate,"
"project," or similar expressions. These forward- looking statements
relate to, among other things, expectations
of the business environment in which the Company operates, projections of
future performance, potential future
performance, perceived opportunities in the market, and statements regarding
the Company's mission and vision.
The Company's actual results, performance,
and achievements may differ materially from the results, performance,
and achievements expressed or implied in such forward-looking statements due to
a wide range of factors which
are set forth in our annual report on Form 10-KSB on file with the SEC.
Read this legal notes before you do
anything else:
+=+=+=+=+=+=+=+=+=+=+=+=+=+=+=+=+=+=+=+=
Information within this email contains" forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and Section 21B
of the Securities Exchange Act of 1934.Any statements that express or involve
with respect to predictions, goals, expectations,
beliefs, plans, projections, objectives, assumptions or future events or
performance are not statements of historical fact and maybe "forward looking
statements.
Forward looking statements are based on
expectations, estimates and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through the use of
words such as: "projects", "foresee"," expects",
"estimates," "believes," understands" "will,"
"part of:" anticipates," or that by statements indicating
certain actions "may," could," or "might" occur.
All information provided within this email pertaining to investing, stocks,
securities must be understood as information provided and not investment
advice. Investor Alert advises all readers and subscribers to seek advice from
a registered professional securities representative before deciding to trade in
stocks featured within this email. None of the material within this report
shall be construed as any kind of investment advice. Please have in mind that
the interpretation of the writer of this newsletter about the news published by
the company does not represent the company official statement and in fact may
differ from the real meaning of what the news release meant to say.
Look at the news release by yourself and judge by yourself about the
details in it.
In compliance with Section 17(b), we disclose the holding of EVRX shares prior
to the publication of this report. Be aware of an inherent conflict of interest
resulting from such holdings due to our intent to profit from the liquidation
of these shares. Shares may be sold at any time, even after positive statements
have been made regarding the above company. Since we own shares, there is an
inherent conflict of interest in our statements and opinions. Readers of this
publication are cautioned not to place undue reliance on forward-looking
statements, which are based on certain assumptions and expectations involving
various risks and uncertainties, that could cause
results to differ materially from those set forth in the forward-looking
statements.
MO55TH1MJXORHNAP3EY4VWK85U3BUV U8W2IEE88H;
